Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

published : Dec, 15 2025

Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

Many older adults take medications every day to manage pain, allergies, bladder issues, or depression. But what if some of those everyday pills are quietly harming their memory and thinking? That’s the reality of anticholinergic burden - a hidden risk built into dozens of common prescriptions and over-the-counter drugs. It’s not a disease. It’s not a rare side effect. It’s a cumulative, measurable threat to brain health that’s been overlooked for decades.

What Exactly Is Anticholinergic Burden?

Anticholinergic burden is the total impact of all medications that block acetylcholine, a key chemical in the brain that helps with memory, attention, and learning. Think of acetylcholine as the brain’s messenger for staying sharp. When drugs block it, signals slow down. Over time, this isn’t just temporary confusion - it’s linked to lasting brain changes.

The most widely used tool to measure this is the Anticholinergic Cognitive Burden (ACB) scale. It rates drugs from Level 1 (mild) to Level 3 (strong). A single Level 3 drug like oxybutynin for overactive bladder adds 3 points. Two Level 2 drugs? That’s 4 points. Add a diphenhydramine (Benadryl) for sleep? Now you’re at 5. And here’s the kicker: research shows that once your total ACB score hits 3 or higher, your risk of cognitive decline starts climbing. At 6 or more, the risk jumps sharply.

Which Medications Are the Biggest Culprits?

Not all anticholinergics are created equal. Some are obvious - like tricyclic antidepressants or older bladder drugs. Others are hiding in plain sight.

  • First-generation antihistamines: Diphenhydramine (Benadryl), chlorpheniramine. These are in dozens of sleep aids and cold medicines. Even one pill a night adds up.
  • Overactive bladder drugs: Oxybutynin, tolterodine, solifenacin. Oxybutynin is a Level 3 - the strongest category. It crosses into the brain easily.
  • Tricyclic antidepressants: Amitriptyline, nortriptyline. Often prescribed for nerve pain or depression, even though safer options exist.
  • Some Parkinson’s and motion sickness drugs: Trihexyphenidyl, scopolamine patches.
  • Older antipsychotics: Chlorpromazine, thioridazine.
A 2023 analysis of Medicare prescriptions found that 18.3% of high-burden prescriptions were for diphenhydramine alone. That’s over 1 million older Americans taking a sleep aid that’s known to impair memory. And most don’t realize it’s even a problem.

How These Drugs Change the Brain

It’s not just about feeling foggy. Brain scans show real, physical damage.

A 2016 study in JAMA Neurology found that older adults taking medium-to-high anticholinergic drugs had 4% less glucose use in the temporal lobe - the same area that shuts down early in Alzheimer’s. Another study tracked brain shrinkage over three years. People on these medications lost brain volume 0.24% faster per year than those not taking them. That’s the equivalent of aging an extra two years in just three years.

Why? Because acetylcholine receptors (M1 type) are packed in the hippocampus and cortex - the brain’s memory and decision-making centers. When drugs block those receptors, brain cells don’t communicate as well. Over time, they start to weaken. And unlike a broken bone, the brain doesn’t always heal after long-term exposure.

What Cognitive Skills Are Most Affected?

Not all thinking skills drop at the same rate. Research from the ASPREE trial - which followed over 19,000 people aged 70+ - shows clear patterns:

  • Executive function: Planning, multitasking, problem-solving. Each 1-point increase in ACB score meant a 0.15-point drop per year on tests like word fluency.
  • Episodic memory: Remembering recent events or conversations. A 1-point ACB rise linked to a 0.08-point annual decline in recall tests.
  • Processing speed: How fast you react or complete simple tasks. This showed almost no decline - meaning the brain’s speed isn’t the main issue. It’s the ability to hold onto and use information.
That’s why older adults on these drugs often say, “I forget where I put my keys,” or “I can’t follow a conversation anymore.” It’s not just aging. It’s the medication.

Split brain image showing cognitive decline on one side and recovery on the other, with medical professionals removing harmful pills.

How Long Does It Take to Cause Damage?

It’s not just what you take - it’s how long you take it.

A landmark 2015 study found that people who took anticholinergic drugs for three years or more had a 54% higher risk of developing dementia compared to those who took them for less than three months. Even low doses, if taken daily for years, add up. And here’s the scary part: many people don’t realize they’re on these drugs. A 2021 survey found that 63% of older adults were never told about the cognitive risks when prescribed these medications.

One caregiver on AgingCare.com shared: “My mom was confused all the time. Her doctor said it was just dementia. We didn’t know her bladder pill - oxybutynin - was a Level 3 anticholinergic. We stopped it. Two weeks later, she was back to herself.”

Can You Reverse the Damage?

Yes - but it takes time and careful planning.

The DICE trial, which studied 286 older adults, showed that after 12 weeks of gradually stopping anticholinergic drugs, participants improved their Mini-Mental State Exam (MMSE) scores by 0.82 points on average. That’s not a cure, but it’s meaningful. For someone struggling with daily tasks, that’s the difference between managing on their own and needing help.

But you can’t just quit cold turkey. Some drugs, like antidepressants or bladder meds, need to be tapered slowly to avoid withdrawal or worsening symptoms. That’s why a medication review with a doctor or pharmacist is essential.

What Are the Alternatives?

There are almost always safer options.

  • For allergies: Use loratadine (Claritin), cetirizine (Zyrtec), or fexofenadine (Allegra). These are non-sedating and have almost no anticholinergic effect.
  • For overactive bladder: Mirabegron (Myrbetriq) works differently - it doesn’t block acetylcholine. Solifenacin (VESIcare) has lower brain penetration than oxybutynin.
  • For depression or pain: SSRIs like sertraline or SNRIs like duloxetine are much safer for the brain than amitriptyline.
  • For sleep: Avoid diphenhydramine. Try melatonin, cognitive behavioral therapy for insomnia (CBT-I), or better sleep hygiene.
Pharmaceutical companies are responding. Johnson & Johnson pulled long-acting oxybutynin off the market in 2021. Pfizer pushed solifenacin as a lower-risk alternative. The FDA now requires stronger warning labels on all anticholinergic drugs.

Older adults living actively with safer medications, smiling under a sunset with a 'Clear Mind Ahead' message.

Why Isn’t This Done More Often?

The problem isn’t lack of evidence. It’s lack of action.

A 2022 study found that only 38.7% of nursing home residents with high anticholinergic burden had their meds reviewed within three months of being flagged. Primary care doctors say they need 23 minutes per patient to do a full review - but most appointments last 10 to 15 minutes.

Plus, many doctors still think, “It’s just a little drowsiness,” or “She’s old - this is normal.” But the American Geriatrics Society’s 2023 Beers Criteria says clearly: avoid strong anticholinergics in older adults. Period.

What Should You Do?

If you or a loved one is over 65 and taking any of these drugs, here’s what to do:

  1. Make a full list: Write down every pill, patch, and OTC medicine - even the ones you only take occasionally.
  2. Check the ACB score: Use the free American Geriatrics Society’s ACB Calculator (launched in 2024) to see your total burden.
  3. Ask your doctor: “Is this drug necessary? Is there a safer alternative?” Don’t be afraid to push back.
  4. Don’t stop suddenly: Work with your provider to taper off safely.
  5. Track changes: Note if memory, focus, or confusion improves over the next 4 to 8 weeks.
The National Institute on Aging is now funding a $14.7 million study called CHIME to see if reducing anticholinergic burden can delay dementia. Early signs are promising. And experts now agree: anticholinergic burden is one of the top 10 modifiable risk factors for dementia.

It’s Not About Fear - It’s About Choice

No one should live with brain fog because they didn’t know their medication was the cause. These drugs aren’t evil. They work. But for older adults, the cost to the brain is too high - especially when safer options exist.

The good news? You can do something about it. A simple conversation with a doctor, a careful review of your meds, and a switch to a non-anticholinergic alternative could mean clearer thinking, better memory, and more independence for years to come.

Can anticholinergic medications cause dementia?

Anticholinergic medications don’t directly cause dementia, but long-term use significantly increases the risk. Studies show that taking these drugs for three or more years raises dementia risk by 54%. They accelerate cognitive decline, particularly in memory and executive function, and are linked to brain changes seen in early Alzheimer’s. Experts now classify anticholinergic burden as one of the top 10 modifiable risk factors for dementia.

Is Benadryl safe for seniors?

No, Benadryl (diphenhydramine) is not safe for regular use in older adults. It’s a strong anticholinergic (ACB Level 3) and is linked to confusion, memory loss, and increased dementia risk. Even one pill at night can build up over time. Safer alternatives include loratadine (Claritin) or cetirizine (Zyrtec), which don’t cross into the brain and have minimal cognitive effects.

How long does it take for cognitive function to improve after stopping anticholinergics?

Cognitive improvements can start within 2 to 4 weeks after stopping, but full recovery may take 4 to 12 weeks. The DICE trial showed measurable gains in memory and thinking tests after 12 weeks of deprescribing. Some people notice clearer thinking sooner, especially if the drug was causing daily confusion. Patience and monitoring are key.

What is the ACB scale, and how do I use it?

The Anticholinergic Cognitive Burden (ACB) scale rates medications from 0 (no effect) to 3 (strong effect) based on their impact on the brain. You add up the scores of all your medications. A total of 3 or more is considered high risk. The American Geriatrics Society offers a free mobile app (ACB Calculator) where you can enter your meds and instantly get your score. Many pharmacists can also help you calculate it.

Are there any new medications that are safer for seniors?

Yes. For overactive bladder, mirabegron (Myrbetriq) and solifenacin (VESIcare) are much safer than older drugs like oxybutynin. For depression, SSRIs like sertraline or escitalopram have far less anticholinergic effect than amitriptyline. For allergies, second-generation antihistamines like loratadine are preferred. Newer drugs are designed to avoid crossing the blood-brain barrier, reducing cognitive side effects.

Why don’t doctors always know about anticholinergic burden?

Many doctors were never trained on anticholinergic burden, and it’s not always visible in electronic health records. Medication reviews take time - about 23 minutes per patient - but most appointments are under 15 minutes. Also, some doctors assume cognitive decline is just aging. But guidelines from the American Geriatrics Society and FDA now clearly warn about these risks, and awareness is growing.

Comments (11)

Michelle M

It’s wild how we normalize brain fog as just ‘getting older’ when it’s often just a pill away from being fixed. I’ve seen my grandma bounce back after switching from Benadryl to melatonin-like someone turned a dim light back on. We don’t have to accept decline. We can ask better questions.

Cassie Henriques

ACB score is a game-changer. I run it on every med my 78yo dad takes. Oxybutynin was at 3, diphenhydramine at 3, amitriptyline at 2-total 8. That’s a 60% higher dementia risk. We switched to mirabegron and sertraline. His MMSE improved 1.2 points in 10 weeks. This isn’t anecdotal-it’s pharmacokinetics.

Lisa Davies

Thank you for this. 🙏 My mom was on 4 anticholinergics and thought she was just ‘forgetful.’ We did the ACB calc-score of 7. We tapered slowly, and now she’s remembering our birthdays again. Not a miracle. Just medicine that doesn’t murder your mind.

Raj Kumar

in india too many old people on avil and cetirizine thinking its harmless. no one tells them. pharmacy guy just sells. need more awareness. my aunt stopped benadryl and slept better and remembered names. simple things matter

Mike Nordby

The data here is robust, but implementation remains fragmented. The disconnect between clinical evidence and prescribing behavior reflects systemic underinvestment in geriatric pharmacology education. The 23-minute review requirement is not a luxury-it’s a clinical imperative. Without structured deprescribing protocols, even the best guidelines remain theoretical.

RONALD Randolph

THIS IS WHY AMERICA IS FALLING APART!!

Doctors don’t care!! Pharmacies push pills!! Seniors take whatever’s handed to them!!

And now we’re paying for it with dementia epidemics!!

STOP GIVING OLD PEOPLE DRUGS THAT TURN THEM INTO ZOMBIES!!

THEY’RE NOT ‘AGING’-THEY’RE BEING POISONED!!

THE FDA IS ASLEEP!!

Benjamin Glover

How quaint. In the UK, we’ve had deprescribing guidelines since 2010. Your ‘ACB calculator’ is merely catching up to what European geriatricians have known for decades. The real tragedy isn’t the drugs-it’s the cultural ignorance.

John Samuel

Imagine a world where your grandmother’s memory isn’t collateral damage from a $2.99 sleep aid. Where ‘just a little drowsiness’ isn’t shrugged off as the price of peace. These aren’t just medications-they’re silent thieves, siphoning away the very essence of who we are: our thoughts, our stories, our ability to recognize a loved one’s smile. We’ve weaponized convenience. And now, the bill is coming due-in forgotten birthdays, lost conversations, and hollow eyes that once sparkled with wisdom.

Let’s not wait for a dementia diagnosis to ask: ‘What did we do to them?’

Nupur Vimal

i know this is real because my uncle took oxybutynin for 5 years and forgot his own son's name and the doctor said its normal aging but then he stopped it and he remembered everything after 3 weeks so stop lying to old people

Jake Sinatra

Every time I see an elderly patient on diphenhydramine, I ask: ‘Is this helping them live-or just helping them sleep through life?’ We have the tools, the data, the alternatives. What we lack is the collective will to prioritize cognitive health over convenience. This isn’t just a medical issue. It’s a moral one.

Sai Nguyen

America is weak. In India we don’t let old people take these drugs. We use herbs. We respect elders. You poison them with pills and then blame their age. Shame.

Write a comment

about author

Matt Hekman

Matt Hekman

Hi, I'm Caspian Braxton, a pharmaceutical expert with a passion for researching and writing about medications and various diseases. My articles aim to educate readers on the latest advancements in drug development and treatment options. I believe in empowering people with knowledge, so they can make informed decisions about their health. With a deep understanding of the pharmaceutical industry, I am dedicated to providing accurate and reliable information to my readers.

our related post

related Blogs

Exploring 2024 Alternatives for Flagyl: Key Options with Benefits and Drawbacks

Exploring 2024 Alternatives for Flagyl: Key Options with Benefits and Drawbacks

Flagyl, known for treating various infections, has several alternatives available in 2024. This article explores six prominent options, including Tinidazole, Solosec, Cleocin, Vancocin, Alinia, and Dificid, each offering unique benefits and drawbacks. By understanding these alternatives, patients can better navigate treatment choices for infections like bacterial vaginosis, giardiasis, and Clostridium difficile. While some alternatives offer convenient dosing schedules or fewer side effects, others may be more expensive or limited in their effectiveness for specific infections. This comprehensive guide helps in evaluating the right treatment fit.

Read More
Generic Prescribing Incentives: How States Push Doctors and Pharmacies to Choose Cheaper Drugs

Generic Prescribing Incentives: How States Push Doctors and Pharmacies to Choose Cheaper Drugs

States use copay differentials, pharmacist substitution rules, and preferred drug lists to push doctors and patients toward cheaper generic medications. These policies save billions but face challenges from rebate systems and supply shortages.

Read More
Common Variable Immunodeficiency: Understanding Antibody Deficiency and Treatment Options

Common Variable Immunodeficiency: Understanding Antibody Deficiency and Treatment Options

Common Variable Immunodeficiency (CVID) is a lifelong antibody deficiency that causes frequent infections and autoimmune problems. Learn how immunoglobulin therapy works, what symptoms to watch for, and how to manage this complex condition effectively.

Read More